Study on aryl hydrocarbon receptor nuclear translocator&nbsp; regulating hypoxic pathway to promote skeletal muscle regeneration in mice

doi:10.13418/j.issn.1001-165x.2021.06.011

PDF(6084 KB)

Chinese Journal of Clinical Anatomy ›› 2021, Vol. 39 ›› Issue (6) : 673-679. DOI: 10.13418/j.issn.1001-165x.2021.06.011

Study on aryl hydrocarbon receptor nuclear translocator regulating hypoxic pathway to promote skeletal muscle regeneration in mice

Li Bin, Zhang Yuteng, Lu Feng

Author information +

History +

Abstract

Objective　To explore the regulatory role of aryl hydrocarbon receptor nuclear transporter (ARNT) on skeletal muscle regeneration and to provide theories for improving muscle regeneration in aging population.　Methods　Mice skeletal muscle injury model was constructed. Skeletal muscle regeneration ability was explored between young and old mice, transgenic and wild-type mice, old hypoxia pathway activator (ML228) and DMSO mice following cryoinjury. Whole muscle was obtained and analyzed to evaluate the expressions of ARNT, hypoxia pathway and skeletal muscle regeneration related protein/ genes, as well as the blood flow in the lower limbs of mice.　Results　The regeneration ability of skeletal muscle decreased in aging mice. ARNT gene knockout in young mice hindered skeletal muscle regeneration, as well as down-regulated hypoxia pathway factor and the expressions of related genes. ML228 could restore the regenerative ability of damaged skeletal muscle.　Conclusions　The inhibition of hypoxia pathway by the decreasing of ARNT content caused by aging is the main reason for the decreasing of skeletal muscle regeneration ability. The pharmacological activator of hypoxia signal improves the regeneration ability of skeletal muscle in the elderly is promising.

Key words

Aryl hydrocarbon receptor translocator / 　Skeletal muscle regeneration / 　Hypoxia pathway / 　Hypoxia pathway activator

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

Li Bin, Zhang Yuteng, Lu Feng. Study on aryl hydrocarbon receptor nuclear translocator regulating hypoxic pathway to promote skeletal muscle regeneration in mice[J]. Chinese Journal of Clinical Anatomy. 2021, 39(6): 673-679 https://doi.org/10.13418/j.issn.1001-165x.2021.06.011

References

[1] Aärimaa V, Kääriäinen M, Vaittinen S, et al. Restoration of myofiber continuity after transection injury in the rat soleus[J]. Neuromuscul Disord, 2004, 14(7): 421-428. DOI: 10.1016/j.nmd.2004.03.009.
[2] Majmundar AJ, Lee DSM, Skuli N, et al. HIF modulation of Wnt signaling regulates skeletal myogenesis in vivo[J]. Development, 2015, 142(14): 2405-2412. DOI: 10.1242/dev.123026.
[3] Yang X, Yang SQ, Wang C, et al. The hypoxia-inducible factors HIF1α and HIF2α are dispensable for embryonic muscle development bur are essential for postnatal muscle regeneration[J]. J Biol Chem, 2017, 292(14): 5981-5991. DOI: 10.1074/jbc.M116.756312.
[4] Lee Z, Dennis J, Alsberg E, et al. Imaging stem cell differentiation for cell-based tissue repair[J]. Methods Enzymol, 2012, 506: 247-263. DOI: 10.1016/B978-0-12-391856-7.00037-8.
[5] Urban JD, Budinsky RA, Rowlands JC. Single nucleotide polymorphisms in the human aryl hydrocarbon receptor nuclear translocator (ARNT) gene[J]. Drug Metab Pharmacokinet, 2011, 26(6): 637-645. DOI: 10.2133/dmpk.DMPK-11-SC-031.
[6] Chan YY, Kalpana S, Chang WC, et al. Expression of aryl hydrocarbon receptor nuclear translocator enhances cisplatin resistance by upregulating MDR1 expression in cancer cells[J]. Mol Pharmacol, 2013, 84(4): 591-602. DOI: 10.1124/mol.113.087197.
[7] Obacz J, Pastorekova S, Vojtesek B, et al. Cross-talk between HIF and p53 as mediators of molecular responses to physiological and genotoxic stresses[J]. Mol Cancer, 2013, 12(1): 93. DOI: 10.1186/1476-4598-12-93.
[8] Tomita S, Sinal CJ, Yim SH, et al. Conditional disruption of the aryl hydrocarbon receptor nuclear translocator (Arnt) gene leads to loss of target gene induction by the aryl hydrocarbon receptor and hypoxia-inducible factor 1alpha[J]. Mol Endocrinol, 2000, 14(10): 1674-1681. DOI: 10.1210/mend.14.10.0533.
[9] Theriault JR, Felts AS, Bates BS, et al. Discovery of a new molecular probe ML228: an activator of the hypoxia inducible factor (HIF) pathway[J]. Bioorg Med Chem Lett, 2012, 22(1): 76-81. DOI: 10.1016/j.bmcl.2011.11.077.
[10] Chen H, Li J, Liang S, et al. Effect of hypoxia‑inducible factor‑1/vascular endothelial growth factor signaling pathway on spinal cord injury in rats[J]. Exp Ther Med, 2017, 13(3): 861-866. DOI: 10.3892/etm.2017.4049.